The Context
Millions of families yearn for better ways to support children struggling with anxiety and obsessive-compulsive disorder (OCD), conditions that affect an estimated 1–3% of young people and can significantly disrupt daily life, from school attendance to social development.
While demand for care continues to grow, traditional treatment models often fall short. Many families rely on infrequent, siloed sessions that fail to provide the consistent, holistic support children and families need. At the same time, skepticism around virtual care—particularly for pediatric mental health—creates barriers to adoption, with parents questioning whether remote treatment can truly deliver meaningful outcomes.
InStride Health was founded to address this gap with a differentiated, insurance-backed clinical model designed specifically for pediatric anxiety and OCD. But standing out in a crowded behavioral health market required reshaping perceptions.
To succeed, InStride needed to clearly articulate what made its model more effective, build trust with parents and simultaneously engage investors and healthcare stakeholders with a compelling, credible growth story.
